Adial Pharmaceuticals(ADIL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADIL Adial Pharmaceuticals

盘前交易 01-20 05:02:55 EST

0.2250

-0.0020

-0.88%

最高0.2320	最低0.2220	成交量25.60万
今开0.2245	昨收0.2270	日振幅4.41%
总市值625.03万	流通市值597.17万	总股本2,778万
成交额5.80万	换手率0.96%	流通股本2,654万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":0.225,"timestamp":1768597200000,"preClose":0.227,"halted":0,"volume":255968,"delay":0,"changeRate":-0.008810572687224677,"floatShares":26541000,"shares":27779300,"eps":-0.9289,"marketStatus":"盘前交易","change":-0.002,"latestTime":"01-20 05:02:55 EST","open":0.2245,"high":0.232,"low":0.222,"amount":57958.68833824,"amplitude":0.044053,"askPrice":0.2496,"askSize":100,"bidPrice":0.2059,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.9289,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768919400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":0.225,"postHourTrading":{"tag":"盘后","latestPrice":0.235,"preClose":0.225,"latestTime":"19:42 EST","volume":4791,"amount":1070.2693,"timestamp":1768610527190,"change":0.01,"changeRate":0.044444,"amplitude":0.057333},"volumeRatio":0.8724632626006018,"impliedVol":1.6275,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL","defaultTab":"news","newsList":[{"id":"2593446210","title":"Adial Pharmaceuticals, Inc盘中异动 快速上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593446210?lang=zh_cn&edition=full","pubTime":"2025-12-24 01:21","pubTimestamp":1766510515,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日01时21分，Adial Pharmaceuticals, Inc股票出现异动，股价大幅拉升5.58%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 、Rezolute, Inc.涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为68.37%、44.67%、40.92%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Geovax Labs, Inc.，振幅分别为56.89%、36.36%、34.42%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224012156a46fc59d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224012156a46fc59d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1173173688","title":"Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1173173688","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173173688?lang=zh_cn&edition=full","pubTime":"2025-11-26 21:01","pubTimestamp":1764162098,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals 宣布进行一项约 286 万美元的认股权证诱导交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1144051693","title":"Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议，推动Ad04进入3期开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1144051693","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144051693?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:51","pubTimestamp":1763128263,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals: 根据Eop2会议实施FDA的建议，推动Ad04进入3期开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"1165269421","title":"Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1165269421","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165269421?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:01","pubTimestamp":1758024114,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals在FDA二期临床试验结束会议获得积极反馈后发布AD04项目业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2567429180","title":"Adial Pharmaceuticals, Inc盘中异动 股价大涨6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567429180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567429180?lang=zh_cn&edition=full","pubTime":"2025-09-13 00:58","pubTimestamp":1757696325,"startTime":"0","endTime":"0","summary":"北京时间2025年09月13日00时58分，Adial Pharmaceuticals, Inc股票出现异动，股价急速上涨6.66%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Hcw Biologics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Yd Bio Ltd C/Wts 28/08/2030涨幅较大，Hcw Biologics Inc.、Cocrystal Pharma, Inc.、Polyrizon Ltd.较为活跃，换手率分别为802.03%、776.74%、636.66%，振幅较大的相关个股有Cocrystal Pharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Ethzilla Corporation C/Wts 06/11/2025，振幅分别为78.47%、38.94%、37.30%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913005845978db811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913005845978db811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"1105888236","title":"Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1105888236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105888236?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:31","pubTimestamp":1756902674,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals获纳斯达克180个日历日延期 以重新符合最低买入价规则","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2559091816","title":"Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559091816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559091816?lang=zh_cn&edition=full","pubTime":"2025-08-14 21:34","pubTimestamp":1755178497,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日21时34分，Adial Pharmaceuticals, Inc股票出现波动，股价快速下跌5.90%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Codexis, Inc.、天演药业涨幅较大，Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为73.05%、34.08%、16.28%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Codexis, Inc.、Traws Pharma, Inc.，振幅分别为20.48%、18.74%、14.62%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081421345894e38266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081421345894e38266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2558575446","title":"Adial Pharmaceuticals, Inc盘中异动 大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558575446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558575446?lang=zh_cn&edition=full","pubTime":"2025-08-08 23:39","pubTimestamp":1754667566,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日23时39分，Adial Pharmaceuticals, Inc股票出现异动，股价快速下挫5.17%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Alector, Inc.、Bioxcel Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为564.77%、147.09%、99.77%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为73.00%、62.10%、44.44%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808233927a6db4eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808233927a6db4eeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2557569305","title":"Adial Pharmaceuticals, Inc盘中异动 早盘大幅下挫5.01%报0.392美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569305?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573481,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分，Adial Pharmaceuticals, Inc股票出现异动，股价急速跳水5.01%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Palisade Bio, Inc.、Niagen Bioscience, Inc.、Sarepta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为341.71%、61.87%、20.59%，振幅较大的相关个股有Palisade Bio, Inc.、Xeris制药、Q32 Bio Inc.，振幅分别为14.00%、12.75%、9.21%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213121a6d8f951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213121a6d8f951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2557431693","title":"Adial Pharmaceuticals, Inc盘中异动 下午盘股价大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557431693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557431693?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:50","pubTimestamp":1754416230,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日01时50分，Adial Pharmaceuticals, Inc股票出现异动，股价急速上涨5.87%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为3.70%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药，其主导产品是AD04，用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060150309735c491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060150309735c491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2556838750","title":"Adial Pharmaceuticals, Inc盘中异动 早盘股价大跌9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556838750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556838750?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:31","pubTimestamp":1754314318,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时31分，Adial Pharmaceuticals, Inc股票出现波动，股价大幅下挫9.91%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2176.53%、789.44%、383.83%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为20.97%、15.35%、13.50%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213159a6d28300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213159a6d28300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2555839799","title":"Adial Pharmaceuticals, Inc盘中异动 早盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555839799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555839799?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:37","pubTimestamp":1753969078,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时37分，Adial Pharmaceuticals, Inc股票出现异动，股价急速跳水5.06%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为2.24%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药，其主导产品是AD04，用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121375894c6645e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121375894c6645e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2555805491","title":"Adial Pharmaceuticals, Inc股价上涨11.21% 市值涨123.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555805491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555805491?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:32","pubTimestamp":1753795949,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时32分，Adial Pharmaceuticals, Inc股票出现波动，股价大幅拉升11.21%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Calidi Biotherapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2452.27%、1139.83%、297.11%，振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Scinai Immunotherapeutics Ltd，振幅分别为18.24%、18.20%、18.05%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213229a469c7ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213229a469c7ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2554721827","title":"Adial Pharmaceuticals, Inc盘中异动 股价大涨20.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721827?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:32","pubTimestamp":1753709524,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时32分，Adial Pharmaceuticals, Inc股票出现异动，股价大幅拉升20.58%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为222.64%、81.38%、81.17%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.，振幅分别为35.83%、23.86%、10.21%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213204a6c61588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213204a6c61588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2553735224","title":"Adial Pharmaceuticals, Inc7月23日成交额为57.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553735224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553735224?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:15","pubTimestamp":1753319740,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Adial Pharmaceuticals, Inc成交额为57.38万美元，成交额较昨日减少65.80%，当日成交量为120.60万股。Adial Pharmaceuticals, Inc于2025年7月23日涨1.74%，报0.479美元，该股过去5个交易日涨18.2%，年初至今跌52.6%，过去60日跌30.12%。该公司开发用于治疗成瘾和相关疾病的处方药，其主导产品是AD04，用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091550a6be7bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091550a6be7bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2518276929","title":"Adial Pharmaceuticals, Inc盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276929?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:51","pubTimestamp":1741618263,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时51分，Adial Pharmaceuticals, Inc股票出现异动，股价大幅跳水5.32%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3497.85%、773.50%、700.91%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.34%、41.36%、40.33%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225103abf31a33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225103abf31a33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2517898710","title":"Adial Pharmaceuticals(ADIL.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.15美元，前值为-0.37美元，预期值为-0.33美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517898710","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517898710?lang=zh_cn&edition=full","pubTime":"2025-03-05 06:45","pubTimestamp":1741128356,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals(ADIL.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.15美元，前值为-0.37美元，预期值为-0.33美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05064548524579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADIL"],"gpt_icon":0},{"id":"1184810783","title":"Adial Pharmaceuticals FY 2024 GAAP每股收益$(2.72) 超出预期$(2.97)","url":"https://stock-news.laohu8.com/highlight/detail?id=1184810783","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184810783?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:01","pubTimestamp":1741100473,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals报告季度每股亏损$，超出分析师共识预期的$，超出预期8.42％。这相比去年同期每股亏损$，是24.44％的增长。以上内容来自Benzinga Earnings专栏，原文如下：$Adial Pharmaceuticals$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 8.42 percent. This is a 24.44 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adial Pharmaceuticals FY 2024 GAAP每股收益$(2.72) 超出预期$(2.97)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"gpt_icon":0},{"id":"2516634693","title":"Adial Pharmaceuticals, Inc盘中异动 快速下挫7.01%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634693?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012280,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Adial Pharmaceuticals, Inc股票出现波动，股价急速下跌7.01%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Aeon Biopharma, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为46.98%、22.45%、21.90%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Adial Pharmaceuticals, Inc、Akari Therapeutics Plc，振幅分别为9.35%、7.01%、6.78%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223120a25d3f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223120a25d3f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2514383707","title":"Adial Pharmaceuticals, Inc盘中异动 早盘急速下跌5.18%报0.791美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514383707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514383707?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分，Adial Pharmaceuticals, Inc股票出现异动，股价大幅跳水5.18%。Adial Pharmaceuticals, Inc股票所在的生物技术行业中，整体涨幅为0.85%。Adial Pharmaceuticals, Inc公司简介：Adial Pharmaceuticals Inc是一家处于临床阶段的生物制药公司。该公司开发用于治疗成瘾和相关疾病的处方药，其主导产品是AD04，用于治疗饮酒障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223741a2567bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223741a2567bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ADIL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adialpharma.com","stockEarnings":[{"period":"1week","weight":-0.0702},{"period":"1month","weight":-0.1399},{"period":"3month","weight":-0.3748},{"period":"6month","weight":-0.5013},{"period":"1year","weight":-0.7837},{"period":"ytd","weight":0.0227}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adial Pharmaceuticals, Inc.于2010年11月成立为弗吉尼亚有限责任公司。该公司是一家临床阶段的生物制药公司，专注于开发治疗或预防成瘾和相关疾病的疗法。该公司的研究性新药候选药物AD04正在开发中，作为一种治疗剂，用于治疗酒精使用障碍（“AUD”）。AD04最近在一项3期临床试验中进行了研究，指定为ONWARD试验，用于对具有某些目标基因型的受试者进行AUD的潜在治疗，这些目标基因型是使用伴随诊断基因测试确定的。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.065674},{"month":2,"riseRate":0.285714,"avgChangeRate":0.038631},{"month":3,"riseRate":0,"avgChangeRate":-0.135985},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.019179},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.082775},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.158497},{"month":7,"riseRate":0.571429,"avgChangeRate":0.080123},{"month":8,"riseRate":0.125,"avgChangeRate":-0.073571},{"month":9,"riseRate":0.375,"avgChangeRate":-0.037962},{"month":10,"riseRate":0.25,"avgChangeRate":-0.152838},{"month":11,"riseRate":0.375,"avgChangeRate":0.139286},{"month":12,"riseRate":0.375,"avgChangeRate":0.006709}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adial Pharmaceuticals(ADIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adial Pharmaceuticals(ADIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况